2007;50:2173 95. 204. Venge P, Johnston N, Lindahl B, et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ische- mia. J Am Coll Cardiol. 2009;54:1165 72. 205. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121 35. 206. Mentzer RM Jr, Bartels C, Bolli R, et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the Expedition study. Ann Thorac Surg. 2008;85:1261 70. Hillis et al 2011 ACCF/AHA CABG Guideline e705 207. Turer AT, Hill JA. Pathogenesis of myocardial ischemiareperfusion injury and rationale for therapy. Am J Cardiol. 2010;106:360 8. 208. Ghorbel MT, Cherif M, Mokhtari A, et al. Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery. Physiol Genomics. 2010;42:67 75. 209. Podgoreanu MV, Schwinn DA. New paradigms in cardiovascular med- icine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol. 2005;46:1965 77. 210. Castellheim A, Hoel TN, Videm V, et al. Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg. 2008;85:1994 2002. 211. Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg. 2007;84:823 8. 212. Paulitsch FS, Schneider D, Sobel BE, et al. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study. Coron Artery Dis. 2009;20:100 5. 213. Serrano CV Jr, Souza JA, Lopes NH, et al. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective ran- domized study. 